Cohance Lifesciences Ltd. : Cash Flow Statement
Industry
Phar
BSE Code
543064
Face Value
1.00
Chairman
Mr.Vivek Sharma
NSE Code
COHANCE
Market Lot
1
Group
Not Applicable
ISIN No
INE03QK01018
Book Closure
09/08/2024
You can view Cashflow Statement.
Particulars
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Months
12
12
12
12
12
Source Of Info (AR = Annual Report, PR = Press Release)
AR
AR
AR
AR
AR
FaceValue
1.00
1.00
1.00
1.00
1.00
Net Profit/Loss Before Extraordinary Items And Tax
351.35
408.77
579.39
722.45
413.98
Net CashFlow From Operating Activities
301.03
370.65
484.17
269.89
329.73
Net Cash Used In Investing Activities
-320.94
-381.58
-235.57
-90.36
-257.66
Net Cash Used From Financing Activities
20.81
-13.78
-235.79
-156.41
-76.55
Net Inc/Dec In Cash And Cash Equivalents
0.90
-24.71
12.81
23.12
-4.48
Cash And Cash Equivalents Begin of Year
18.46
43.02
30.21
7.09
11.58
Cash And Cash Equivalents End Of Year
19.36
18.31
43.02
30.21
7.09
Company Info
Type first few letters
*